Advertisement

The effects of oral contraceptives on the results of laboratory tests

  • John B. Miale
    Correspondence
    Reprint requests: Dr. John B. Miale, University of Miami School of Medicine, P. O. Box 875, Biscayne Annex, Miami, Florida 33152
    Affiliations
    Department of Pathology, University of Miami School of Medicine,, Miami, Florida, USA

    Clinical Pathology Laboratories, Jackson Memorial Hospital, Miami, Florida, USA
    Search for articles by this author
  • Jessie W. Kent
    Affiliations
    Department of Pathology, University of Miami School of Medicine,, Miami, Florida, USA

    Clinical Pathology Laboratories, Jackson Memorial Hospital, Miami, Florida, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The literature on the effects of oral contraceptives on the results of clinical laboratory tests has been reviewed critically. One hundred tests are affected significantly. These have been tabulated and, for each, an estimate has been made as to whether the effect is slight, moderate, or severe.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aly H.E.
        • Donald E.A.
        • Simpson M.H.W.
        Am. J. Clin. Nutr. 1971; 24: 297
      1. ed. 3. AMA Drug Evaluations. American Medical Association, Chicago1971
        • Arias I.M.
        Some effects of contraceptive steroids on hepatic function in normal women and in patients with acquired and inheritable defects in hepatic excretory function.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 30-39
        • Banks S.
        • Marks I.N.
        Postgrad. Med. J. 1970; 46: 576
        • Barton G.M.G.
        • Freeman P.R.
        • Lawson J.P.
        J. Obstet. Gynaecol. Br. Commonw. 1970; 77: 551
        • Bass G.
        • Soyka E.
        Praxis. 1972; 61: 1318
        • Beck J.
        Effects of gonadal hormones and contraceptive steroids on glucose and insulin metabolism.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 97-125
        • Beck R.P.
        • Morcos F.
        • Fawcett D.
        • Watanabe M.
        Am. J. Obstet. Gynecol. 1972; 112: 364
        • Beckerhoff R.
        • Luetscher J.A.
        • Wilkinson R.
        • et al.
        J. Clin. Endocrinol. Metab. 1972; 34: 1067
        • Bergsjö P.
        • Fagerhol M.K.
        • Abildgaard U.
        Am. J. Obstet. Gynecol. 1972; 112: 938
        • Bianchine J.R.
        • Bonnlander B.
        • Macaraeg Jr., P.V.J.
        • et al.
        J. Clin. Endocrinol. Metab. 1969; 29: 1425
        • Bick R.L.
        • Thompson W.B.
        Obstet. Gynecol. 1972; 39: 213
        • Bierman E.L.
        Oral contraceptives, lipoproteins and lipid transport.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 207-218
        • Billing B.H.
        • Black M.
        Ann. N. Y. Acad. Sci. 1971; 179: 403
        • Bole Jr., G.G.
        • Friedlaender M.H.
        • Smith C.K.
        Lancet. 1969; 1: 323
        • Brakman P.
        Fibrinolysis in blood during pregnancy and hormone treatment.
        in: Astrup T. Wright I.S. Blood Coagulation, Thrombosis, and Female Hormones. Waverly Press, Baltimore1968: 27-32
        • Briggs M.
        • Briggs M.
        Lancet. 1972; 2: 1037
        • Buchler D.
        • Warren J.C.
        Am. J. Obstet. Gynecol. 1966; 95: 479
        • Bulbrook R.D.
        • Hayward J.L.
        Lancet. 1969; 2: 1033
        • Cain M.D.
        • Walters W.A.
        • Catt K.J.
        J. Clin. Endocrinol. Metab. 1971; 33: 671
        • Carey H.M.
        Med. J. Aust. 1971; 2: 1242
        • Chandra R.K.
        J. Reprod. Fertil. 1972; 28: 463
        • Chapel J.A.
        • Burns R.E.
        Am. J. Obstet. Gynecol. 1971; 110: 366
        • Corredor D.G.
        • Mendelsohn L.V.
        • Sabeh G.
        • Sunder J.H.
        • Danowski T.S.
        Clin. Pharmacol. Ther. 1970; 11: 188
        • Craft I.L.
        • Wise I.
        Lancet. 1969; 2: 1138
        • Degos R.
        • Touraine R.
        • Kalis B.
        • et al.
        Ann. Dermatol. Syphiligr. 1969; 96: 5
        • Deykin D.
        N. Engl. J. Med. 1970; 283: 801
        • di Paola G.
        • Puchulu F.
        • Robin M.
        • Nicholson R.
        • Marti M.
        Am. J. Obstet. Gynecol. 1968; 101: 206
        • Doar J.W.H.
        • Wynn V.
        • Cramp D.G.
        Studies of venous blood pyruvate and lactate levels during oral and intravenous glucose tolerance tests in women receiving oral contraceptives.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Pres, Inc, New York1969: 178-192
        • Dotchev D.
        • Liappis N.
        • Hungerland H.
        Clin. Chim. Acta. 1973; 44: 431
        • Fisch I.R.
        • Freedman S.H.
        Clin. Pharmacol. Ther. 1973; 14: 245
        • Fitzgerald P.H.
        • Pickering A.F.
        • Ferguson D.N.
        Lancet. 1973; 1: 615
        • Gal I.
        • Parkinson C.
        • Craft I.
        Br. Med. J. 1971; 2: 436
        • Genton E.
        Milbank Mem. Fund Q. 1972; 50: 24
        • Gershberg H.
        J. Reprod. Med. 1970; 5: 35
        • Gershberg H.
        • Javier Z.
        • Hulse M.
        Diabetes. 1964; 13: 378
        • Gold E.M.
        • Carvajal J.
        • Rudnick P.A.
        • et al.
        Insulin production in overt (maturityonset) diabetes: Absence of hyperinsulinemia induced by contraceptive steroids.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 144-156
        • Goldberg A.
        Porphyrins and porphyrias.
        in: Goldberg A. Brain M.C. Recent Advances in Haematology. E. & S. Livingstone, Ltd, Edinburgh1971: 302-336
        • Goldsmith N.
        • Goldsmith J.
        Arch. Environ. Health. 1966; 12: 607
        • Goldzieher J.W.
        • Kleber J.W.
        • Moses L.E.
        • et al.
        Contraception. 1970; 2: 225
        • Goldzieher J.W.
        • Rice-Wray E.
        ed. 3. Oral Contraception: Mechanism and Management. Charles C Thomas, Publisher, Springfield, Illinois1966: 93-101
        • Haller J.
        Contraception. 1970; 1: 233
        • Halsted J.A.
        • Hackley B.M.
        • Smith Jr., J.C.
        Lancet. 1968; 2: 278
        • Hansten P.D.
        ed. 3. Drug Interactions. Lea & Febiger, Publishers, Philadelphia1971
        • Hazzard W.R.
        • Spiger M.J.
        • Bagdade J.D.
        • et al.
        N. Engl. J. Med. 1969; 280: 471
        • Hedlin A.M.
        Obstet. Gynecol. 1971; 37: 225
        • Hillmer T.
        • Frerichs H.
        • Creutzfeldt W.
        • et al.
        Verhandl 3 Kongress D. Deutschen Diabetesgesellschaft, Gottingened. 3. Kolenhydrat-und Fettstoffwechselveranderungen wahrend der Behandlung mit einem Ovulations-hemmer (Eugynon). 1968
        • Hollander C.S.
        • Garcia A.M.
        • Sturgis S.N.
        • et al.
        N. Engl. J. Med. 1963; 269: 501
        • Hønger P.E.
        • Rossing N.
        Clin. Sci. 1969; 36: 41
        • Hutcherson W.P.
        • Schwartz H.A.
        • Weathers W.
        • et al.
        Fertil. Steril. 1967; 18: 616
        • Iber F.L.
        Postgrad. Med. 1967; 41: 30
        • Javier Z.
        • Gershberg H.
        • Hulse M.
        Metabolism. 1968; 17: 443
        • Johnson G.K.
        • Geenen J.E.
        • Hensley G.T.
        • et al.
        Am. J. Dig. Dis. 1973; 18: 185
        • Johnson H.W.
        • Lee G.B.
        Minn. Med. 1971; 54: 335
        • Kaffarnik H.
        • Gassel W.-D.
        • Lehnert H.
        • et al.
        Munch. Med. Wochenschr. 1971; 113: 757
        • Kalesh D.G.
        • Mallikar Juneswara V.R.
        • Clemetson C.A.B.
        Contraception. 1971; 4: 183
        • Kalkhoff R.K.
        • Kim H.J.
        • Stoddard F.J.
        Acquired subclinical diabetes mellitus in women receiving oral contraceptive agents.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 193-203
        • Kiran O.
        • Urkuten M.
        • Ozsoylu S.
        Clin. Pediatr. 1970; 9: 656
        • Kistner R.W.
        Drug Ther. 1971; 1: 14
        • Kleiner G.J.
        • Kresch L.
        • Arias I.M.
        N. Engl. J. Med. 1965; 273: 420
        • Laragh J.H.
        • Newton M.A.
        • Sealy J.E.
        • et al.
        Oral contraceptives and high blood pressure: changes in plasma renin, renin substrate, and aldosterone excretion.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 405-421
        • Larsson-Cohn U.
        Br. Med. J. 1965; 1: 1414
        • Larsson-Cohn U.
        Am. J. Obstet. Gynecol. 1967; 98: 188
        • Lipsett M.G.
        • Combs J.W.
        • Catt K.
        • et al.
        Ann. Intern. Med. 1971; 74: 251
        • Loraine J.A.
        • Bell E.T.
        ed. 3. Hormone Assays and Their Clinical Application. The Williams & Wilkins Company, Baltimore1971
        • Lorrain J.
        • Harel P.
        Fertil. Steril. 1972; 23: 422
        • Lucis O.J.
        • Lucis R.
        Bull. W. H. O. 1972; 46: 443
        • Luhby A.L.
        • Brin M.
        • Gordon M.
        • et al.
        Am. J. Clin. Nutr. 1971; 24: 684
        • Luhby A.L.
        • Davis P.
        • Murphy M.
        • et al.
        Lancet. 1970; 2: 1083
        • Lunell N.O.
        • Persson B.
        • Öhqvist G.
        Acta Obstet. Gynecol. Scand. 1973; 52: 23
        • Martin E.W.
        Hazards of Medication. J. B. Lippincott Company, Philadelphia1971: 156-215
        • McQueen E.G.
        Drugs. 1971; 2: 20
        • McLeroy V.J.
        • Schendel H.E.
        Am. J. Clin. Nutr. 1973; 26: 191
        • Mendenhall H.W.
        Am. J. Obstet. Gynecol. 1970; 106: 750
        • Meyler L.
        • Merxheimer A.
        Side Effects of Drugs. vol. 5. Excerpta Medica Foundation, Mouton and Co, The Hague1968
        • Newton M.A.
        • Sealey J.E.
        • Ledingham J.G.G.
        • Laragh J.H.
        Am. J. Obstet. Gynecol. 1968; 101: 1037
        • Nielsen M.D.
        • Binder C.
        • Starup J.
        Acta Endocrinol. 1969; 60: 473
        • Owen C.A.
        • Thompson J.H.
        • Bowie E.J.
        • et al.
        Coagulation studies during pregnancy and hormone treatment.
        in: Astrup T. Wright S. Blood Coagulation, Thrombosis, and Female Hormones. Waverly Press, Baltimore1968
        • Page L.B.
        • Dessaulles E.
        • Lagg S.
        • et al.
        Clin. Chim. Acta. 1971; 34: 55
        • Pehrson S.L.
        Acta Obstet. Gynecol. Scand. 1970; 49: 249
        • Peterson R.A.
        • Krull P.E.
        • Finley P.
        • et al.
        Am. J. Clin. Pathol. 1970; 53: 468
        • Phillips N.
        • Duffy T.
        Am. J. Obstet. Gynecol. 1973; 116: 91
        • Poller L.
        Acta Med. Scand. 1971; 525 (Suppl.): 197
        • Poller L.
        • Priest C.M.
        • Thomson J.M.
        Br. Med. J. 1969; 4: 273
        • Poller L.
        • Thomson J.M.
        • Thomas W.
        Br. Med. J. 1971; 4: 648
        • Poller L.
        • Thomson J.M.
        • Thomas W.
        • et al.
        Br. Med. J. 1971; 1: 705
        • Posner N.A.
        • Silverstone F.A.
        • Pomerance W.
        • et al.
        Obstet. Gynecol. 1967; 29: 79
        • Posner N.A.
        • Silverstone F.A.
        • Pomerance W.
        • et al.
        Obstet. Gynecol. 1967; 29: 87
        • Price S.A.
        • Rose D.P.
        • Toseland P.A.
        Am. J. Clin. Nutr. 1972; 25: 494
        • Rannevik G.
        • Jeppsson S.
        • Kullander S.
        J. Obstet. Gynaecol. Br. Commonw. 1972; 79: 1128
        • Rivers J.M.
        • Devine M.M.
        Fed. Proc. 29. 1970: 295 (Abst.)
        • Roenigk H.H.
        • Gottlob M.E.
        Arch. Dermatol. 1970; 102: 260
        • Rose D.P.
        • Toseland P.A.
        Metabolism. 1973; 22: 165
        • Saruta T.
        • Saade G.A.
        • Kaplan N.M.
        Arch. Intern. Med. 1970; 126: 621
        • Schatz D.L.
        • Palter H.C.
        • Russell C.S.
        Can. Med. Assoc. J. 1968; 99: 882
        • Schenker J.G.
        • Jungreis E.
        • Polishuk W.Z.
        Obstet. Gynecol. 1971; 37: 233
        • Seal U.S.
        • Doe R.P.
        Effects of gonadal and contraceptive hormones on protein and amino acid metabolism.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 277-318
        • Shojania A.M.
        Lancet. 1971; 2: 932
        • Shojania A.M.
        • Hornady G.J.
        • Barnes P.H.
        Lancet. 1969; 1: 886
        • Shojania A.M.
        • Hornady G.J.
        • Barnes P.H.
        Am. J. Obstet. Gynecol. 1971; 111: 782
        • Simpson Jr., W.M.
        South. Med. J. 1971; 64: 1184
        • Spellacy W.N.
        The effect of ovarian steroids on glucose, insulin and growth hormone.
        in: Salhanick H.A. Kipnis D.M. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 126-143
        • Spellacy W.N.
        Am. J. Obstet. Gynecol. 1969; 104: 448
        • Spellacy W.N.
        J. Reprod. Med. 1970; 5: 20
        • Spellacy W.N.
        • Buhi W.G.
        • Birk S.A.
        • et al.
        Fertil. Steril. 1973; 24: 178
        • Spellacy W.N.
        • Buhi W.C.
        • Birk S.A.
        • et al.
        Contraception. 1971; 3: 185
        • Spellacy W.N.
        • Carlson K.L.
        Am. J. Obstet. Gynecol. 1966; 95: 474
        • Spellacy W.N.
        • Zartman E.R.
        • Buhi W.C.
        • et al.
        South. Med. J. 1970; 63: 152
        • Starup J.
        • Date J.
        • Deckert T.
        Acta Endocrinol. 1968; 58: 537
        • Stevens V.C.
        • Goldzieher J.W.
        • Vorys N.
        Am. J. Obstet. Gynecol. 1968; 102: 95
        • Stokes T.
        • Wynn V.
        Lancet. 1971; 2: 677
        • Streiff R.R.
        Clin. Res. 1969; 17: 345
        • Streiff R.R.
        J. A. M. A. 1970; 214: 105
        • Sunderman Jr., F.W.
        CRC Crit. Rev. Clin. Lab. Sci. 1970; 1: 427
        • Szabo A.J.
        • Cole H.S.
        • Grimaldi R.D.
        N. Engl. J. Med. 1970; 282: 646
        • Tatro D.S.
        Hosp. Form Management. 1971; 6: 14
        • Toghill P.J.
        • Smith P.G.
        Br. Med. J. 1971; 1: 608
        • von Kaulla E.
        • Droegemueller W.
        • Aoki N.
        • von Kaulla K.N.
        Am. J. Obstet. Gynecol. 1971; 109: 868
        • Walters W.A.W.
        • Lim Y.L.
        Lancet. 1969; 2: 879
        • Weinberger M.H.
        • Collins R.D.
        • Dowdy A.J.
        • et al.
        Ann. Intern. Med. 1969; 71: 891
        • Wertalik L.F.
        • Metz E.N.
        • Lobuglio A.F.
        • et al.
        Am. J. Clin. Nutr. 1971; 24: 603
        • Wertalik L.F.
        • Metz E.N.
        • Lobuglio A.F.
        • et al.
        J. A. M. A. 1972; 221: 1371
        • Williamson H.O.
        • Moody L.O.
        J. Reprod. Med. 1970; 5: 9
        • Wynn V.
        • Doar J.W.H.
        Lancet. 1966; 2: 715
        • Wynn V.
        • Doar J.W.H.
        Longitudinal studies of the effects of oral contraceptive therapy on plasma glucose, nonesterified fatty acid, insulin and blood pyruvate levels during oral and intravenous glucose tolerance tests.
        in: Salhanick H.A. Kipnis D.W. VandeWiele R.L. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Plenum Press, Inc, New York1969: 157-177
        • Wynn V.
        • Doar J.W.H.
        • Mills G.L.
        Lancet. 1966; 2: 720
        • Young D.S.
        • Thomas D.W.
        • Friedman R.B.
        • et al.
        Clin. Chem. 1972; 18: 1041
        • Young M.M.
        • Jasani C.
        • Smith D.A.
        • et al.
        Clin. Sci. 1968; 34: 411
        • Zuck T.F.
        • Bergin J.J.
        • Raymond J.M.
        • et al.
        Surg. Gynecol. Obstet. 1971; 133: 609